HLS Therapeutics Inc. - 3 year dividend growth rate
Dividend history for stock HLTRF (HLS Therapeutics Inc.) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2034 | 0.226USD * | 8.23% |
| 2033 | 0.210USD * | 7.65% |
| 2032 | 0.195USD * | 7.10% |
| 2031 | 0.181USD * | 6.59% |
| 2030 | 0.168USD * | 6.12% |
| 2029 | 0.156USD * | 5.69% |
| 2028 | 0.145USD * | 5.28% |
| 2027 | 0.134USD * | 4.90% |
| 2026 | 0.125USD * | 4.55% |
| 2025 | 0.116USD * | 4.23% |
| 2024 | 0.108USD * | 3.93% |
| 2023 | 0.100USD | |
| 2022 | 0.200USD | |
| 2021 | 0.170USD | |
| 2020 | 0.200USD | |
| 2019 | 0.200USD | |
| 2018 | 0.050USD | |
| 2014 | 0.180USD | |
| 2013 | 0.220USD | |
| 2010 | 0.200USD |
* These yearly dividends are calculated as current last years dividends times conservative dividend growth rate. Conservative dividend growth rate is calculated from DGR3 value and uses this function (in HLTRF case 7.69% was used as conservative DGR).
HLTRF
Price: $2.74
Dividend Yield: 5.47%
Forward Dividend Yield: 3.65%
Dividend Per Share: 0.10 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 100
Market Capitalization: 88.0 million
Average Dividend Frequency: 3
Years Paying Dividends: 6
DGR3: 7.69%